ID: ALA2373292

Max Phase: Preclinical

Molecular Formula: C110H163N25O31S5

Molecular Weight: 2491.99

Molecule Type: Protein

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CSSC[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H]2CSSC[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O

Standard InChI:  InChI=1S/C110H163N25O31S5/c1-14-57(8)87(107(163)125-76(109(165)166)40-61-44-114-66-25-19-18-24-64(61)66)134-99(155)77(43-110(10,11)12)126-108(164)88(58(9)139)135-98(154)71(37-55(4)5)119-96(152)74(41-62-45-113-53-115-62)122-103(159)81-50-169-168-49-65(112)89(145)127-78(46-136)102(158)132-82-51-170-171-52-83(105(161)133-86(56(6)7)106(162)124-73(39-60-27-29-63(140)30-28-60)94(150)121-72(95(151)131-81)38-59-22-16-15-17-23-59)130-91(147)68(31-32-84(141)142)117-90(146)67(26-20-21-34-111)116-97(153)75(42-85(143)144)123-92(148)69(33-35-167-13)118-93(149)70(36-54(2)3)120-100(156)79(47-137)128-101(157)80(48-138)129-104(82)160/h15-19,22-25,27-30,44-45,53-58,65,67-83,86-88,114,136-140H,14,20-21,26,31-43,46-52,111-112H2,1-13H3,(H,113,115)(H,116,153)(H,117,146)(H,118,149)(H,119,152)(H,120,156)(H,121,150)(H,122,159)(H,123,148)(H,124,162)(H,125,163)(H,126,164)(H,127,145)(H,128,157)(H,129,160)(H,130,147)(H,131,151)(H,132,158)(H,133,161)(H,134,155)(H,135,154)(H,141,142)(H,143,144)(H,165,166)/t57-,58+,65+,67+,68-,69+,70?,71-,72-,73+,74-,75-,76-,77-,78-,79+,80-,81-,82+,83+,86-,87-,88-/m0/s1

Standard InChI Key:  FYQSINZSEYBXAC-JHVPVJJZSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Protein

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 2491.99

Molecular Weight (Monoisotopic): 2490.0550

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Kikuchi T, Kubo K, Ohtaki T, Suzuki N, Asami T, Shimamoto N, Wakimasu M, Fujino M..  (1993)  Endothelin-1 analogues substituted at both position 18 and 19: highly potent endothelin antagonists with no selectivity for either receptor subtype ETA or ETB.,  36  (25): [PMID:8258832] [10.1021/jm00077a013]

Source

Source(1):

• Scientific Literature